compounded glp 1 injections GLP-1 GLP-1 Weight Loss Options |

The anti-inflammatory properties of GLP-1 agonists additionally contribute to their cardiovascular benefits

S.NielsenR.HnselmannA.et al (2017)

These physiological changes may underlie the observed reduction in HFpEF events observed in the main trial

Both the GLP-1R/GIP coagonist and the tri-agonist similarly reduced blood glucose levels and improved glucose tolerance without induction of hypoglycaemia, and this demonstrates that chronic GCGR agonism does not overpower the anti-hyperglycemic effects of GLP-1R and GIPR activation

Today, I spoke live with Paul Bagnell, news anchor with Bloomberg BNN, on the topic of the GLP-1 agonists and their impact on health care, industries beyond health and medicine, and consumers